Aptinyx Inc. Common Stock
APTX
APTX was delisted on the 18th of May, 2023.
59 hedge funds and large institutions have $55.9M invested in Aptinyx Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 24 increasing their positions, 9 reducing their positions, and 9 closing their positions.
167% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 9
67% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 9
11% more funds holding
Funds holding: 53 → 59 (+6)
2% less capital invested
Capital invested by funds: $57.3M → $55.9M (-$1.4M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$10.9M |
| 2 |
AG
Artal Group
Luxembourg
|
+$5.45M |
| 3 |
ASP
Adams Street Partners
Chicago,
Illinois
|
+$3.57M |
| 4 |
O
OrbiMed
New York
|
+$3.33M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
+$1.93M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$1.4M |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$533K |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$431K |
| 4 |
MA
MYDA Advisors
Woodmere,
New York
|
-$329K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$300K |
APTX Hedge Fund Activity: Q1 2020 in Review
59 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Aptinyx Inc. Common Stock (APTX) for Q1 2020, worth a combined $55.9M — down 2.4% from $57.3M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new APTX positions and 9 closed out — a net gain of 6 holders — while 24 added to existing stakes and 9 trimmed.
The largest buyer was Bain Capital Life Sciences Investors, adding an estimated $10.9M. The largest seller was Farallon Capital Management, exiting entirely with an estimated $1.4M sold.
- 59 institutional investors held Aptinyx Inc. Common Stock (APTX) as of Q1 2020, up from 53 in Q4 2019.
- Funds reported $55.9M of Aptinyx Inc. Common Stock stock for Q1 2020, down 2.4% quarter-over-quarter.
- 15 funds opened new Aptinyx Inc. Common Stock positions in Q1 2020 and 9 closed out, a net change of +6 holders.
- The largest Aptinyx Inc. Common Stock buyer in Q1 2020 was Bain Capital Life Sciences Investors, an estimated $10.9M added.
- The largest Aptinyx Inc. Common Stock seller in Q1 2020 was Farallon Capital Management, an estimated $1.4M sold.
Based on aggregated 13F filings for Q1 2020.